Navigation Links
New breast cancer committee to establish federal research agenda

A newly formed advisory committee will develop and coordinate a strategic federal research agenda on environmental and genetic factors related to breast cancer. The 19-member Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) was established by the National Institute of Environmental Health Sciences (NIEHS), in collaboration with the National Cancer Institute (NCI), to review all breast cancer research efforts conducted or supported by federal agencies.

The committee will develop recommendations for the secretary of the U.S. Department of Health and Human Services, the National Institutes of Health, and other federal agencies, to improve existing research programs related to breast cancer research. Additionally, the IBCERCC will create a comprehensive plan to expand opportunities for collaborative, multi-disciplinary research, and develop a summary of advances in federal breast cancer research.

"The broad range of expertise and insight of these individuals will ensure the federal research portfolio continues to advance our understanding of the critical links between our environment, our genes, and our health," said Linda Birnbaum, Ph.D., director of NIEHS and the National Toxicology Program (NTP).

"The committee's focus on breast cancer and the environment research across federal agencies will be valuable in identifying scientific opportunities to better understand the impact of the environment on this disease," said Robert Croyle, Ph.D., director of the Division of Cancer Control and Population Sciences at NCI.

The IBCERCC is comprised of 19 voting members, including representatives of federal agencies; non-federal scientists, physicians, and other health professionals from clinical, basic, and public health sciences; and advocates for individuals with breast cancer.

The first meeting of the IBCERCC will take place Sept. 30 Oct. 1, 2010 in the Washington, D.C., area.

Federal Representatives

Christine Ambrosone, Ph.D.
Member, Board of Scientific Advisors, National Cancer Institute, and
Professor of Oncology, Roswell Park Cancer Institute

Sally Darney, Ph.D.
Acting National Program Director, Human Health Research Program
U.S. Environmental Protection Agency

Suzanne Fenton, Ph.D.
Reproductive Endocrinologist
National Institute of Environmental Health Sciences

Vivian Pinn, M.D.
Director, Office of Research on Women's Health
National Institutes of Health

Marcus Plescia, M.D., M.P.H.
Director, Division of Cancer Prevention and Control
Centers for Disease Control and Prevention

Gayle Vaday, Ph.D.
Program Manager, Breast Cancer Research Program, Congressionally Directed Medical Research Programs, U.S. Department of Defense

Shelia Hoar Zahm, Sc.D.
Deputy Director, Division of Cancer Epidemiology and Genetics
National Cancer Institute

Non-Federal Representatives (Scientists, Physicians, and other Health Professionals)

Michele Forman, Ph.D.
Professor of Epidemiology
The University of Texas M.D. Anderson Cancer Center

Michael Gould, Ph.D.
Professor of Oncology
University of WisconsinMadison

Sandra Haslam, Ph.D.
Professor of Physiology
Michigan State University

Ronda Henry-Tillman, M.D.
Medical Director, Women's Oncology Clinic and Director, Cancer Control Arkansas Cancer Research Center, University of Arkansas for Medical Sciences

Kenneth Portier, Ph.D.
American Cancer Society

Cheryl Walker, Ph.D.
Professor of Carcinogenesis
The University of Texas M.D. Anderson Cancer Center

Non-Federal Representatives (Advocates)

Janice Barlow, P.H.N., C.P.N.P.C.
Executive Director
Zero Breast Cancer

Beverly Canin
Breast Cancer Options

Alice Chang, Ph.D.
President and Co-Founder
Academy for Cancer Wellness

Karen Joy Miller
Founder and President
Huntington Breast Cancer Action Coalition

Laura Nikolaides, M.S.
Director, Research & Quality Care Program
National Breast Cancer Coalition

Jeanne Rizzo, R.N.
President and CEO
Breast Cancer Fund

The business of the committee will be facilitated by federal officials including Linda Birnbaum, Ph.D., director of NIEHS and the NTP; Harold Varmus, M.D., director of NCI; Gwen Collman, Ph.D., interim director of the NIEHS Division of Extramural Research and Training; Deborah Winn, Ph.D., deputy director of the NCI Division of Cancer Control and Population Sciences; Dale Sandler, Ph.D., chief of the NIEHS Epidemiology Branch; and Neeraja Sathyamoorthy, Ph.D., program director of the NCI Division of Cancer Biology's Tumor Biology and Metastasis Branch.


Contact: Ed Kang
NIH/National Institute of Environmental Health Sciences

Related biology news :

1. 1,500 worldwide experts debate the latest advances in breast pathologies treatments in Valencia
2. K-State research team investigates mutated genes role in breast cancer
3. Komen grant supports research into suspicious gene tied to breast cancer
4. Study finds diet and alcohol alter epigenetics of breast cancer
5. Study links African ancestry to high-risk breast cancer
6. New arsenic nanoparticle blocks aggressive breast cancer
7. Fish oil may reduce risk of breast cancer
8. Treating tongue tie could help more babies breastfeed
9. Probiotic found in breast milk helps alleviate symptoms of digestive disorders
10. Prenatal exposure to BPA and DES may increase breast cancer risk
11. Study raises new concerns about radiation and breast cancer
Post Your Comments:
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
Breaking Biology Technology: